# iDEL Therapeutics

**Source:** https://www.startuphub.ai/startups/idel-therapeutics
**Profile type:** Startup

> Developing a pipeline of cancer therapeutics delivered directly into the cytosol of tumor cells.

## About

iDEL Therapeutics is a Dortmund-based startup focused on developing novel cancer therapeutics. Their core technology is a synthetic shuttle platform designed to deliver drugs directly into the cytosol of tumor cells, evading endosomal trapping and preventing degradation. This platform is compatible with both large and small molecules, including nanobodies and cytotoxic payloads, aiming to unlock historically undruggable intracellular targets and broaden therapeutic windows. The company is advancing two proprietary lead programs towards clinical evaluation, with a focus on addressing a range of solid tumors. iDEL Therapeutics also aims to create scalable value through partnerships.

## Key facts

- **Slug:** idel-therapeutics
- **Website:** https://www.idel-tx.com
- **Location:** Dortmund, Germany
- **Founded:** 2025-01-01 00:00:00
- **Operating status:** Active
- **Total funding:** $10M
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Oncology, Drug Delivery
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/idel-therapeutics-gmbh

## Frequently asked

### What does iDEL Therapeutics do?

iDEL Therapeutics is a Dortmund-based startup focused on developing novel cancer therapeutics. Their core technology is a synthetic shuttle platform designed to deliver drugs directly into the cytosol of tumor cells, evading endosomal trapping and preventing degradation. This platform is compatible with both large and small molecules, including nanobodies and cytotoxic payloads, aiming to unlock historically undruggable intracellular targets and broaden therapeutic windows. The company is advanc…

### What is iDEL Therapeutics's revenue?

StartupHub estimates iDEL Therapeutics's annual revenue at $1.2M (range $367K to $3.6M, 34% confidence), based on comparable companies in the sector.

### What is iDEL Therapeutics's valuation?

StartupHub estimates iDEL Therapeutics's effective valuation at $37.9M (range $24.3M to $58.3M, 23% confidence), based on comparable companies in the sector.

### How much funding has iDEL Therapeutics raised?

iDEL Therapeutics has raised a total of $10M in funding. The most recent round on record is Seed.

### Where is iDEL Therapeutics headquartered?

iDEL Therapeutics is headquartered in Dortmund, Germany.

### When was iDEL Therapeutics founded?

iDEL Therapeutics was founded in 2025.

### What industry does iDEL Therapeutics operate in?

iDEL Therapeutics operates in Biotechnology, Pharmaceuticals, Oncology, Drug Delivery.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "iDEL Therapeutics",
          "item": "https://www.startuphub.ai/startups/idel-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/idel-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/idel-therapeutics",
      "name": "iDEL Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of iDEL Therapeutics. iDEL Therapeutics is a startup founded in 2025, operating in Biotechnology and Pharmaceuticals. Developing a pipeline of cancer therapeutics delivered directly into the cytosol of tumor cells. Headquartered in Dortmund, Germany.",
      "dateModified": "2026-05-15T09:27:57.274+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/idel-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/idel-therapeutics#organization",
      "name": "iDEL Therapeutics",
      "url": "https://www.idel-tx.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/ee685468-9042-4f08-b4c0-38c4a7b4c8dd-square.png",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/ee685468-9042-4f08-b4c0-38c4a7b4c8dd-square.png",
      "description": "This is the official profile of iDEL Therapeutics. iDEL Therapeutics is a startup founded in 2025, operating in Biotechnology and Pharmaceuticals. Developing a pipeline of cancer therapeutics delivered directly into the cytosol of tumor cells. Headquartered in Dortmund, Germany.",
      "sameAs": [
        "https://www.linkedin.com/company/idel-therapeutics-gmbh",
        "https://www.startuphub.ai/startups/idel-therapeutics"
      ],
      "foundingDate": "2025-01-01 00:00:00",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Dortmund",
        "addressCountry": "Germany"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Oncology",
        "Drug Delivery"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/idel-therapeutics#profile-assessment",
      "name": "iDEL Therapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/idel-therapeutics",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/ee685468-9042-4f08-b4c0-38c4a7b4c8dd-square.png",
      "category": "Biotechnology",
      "description": "This is the official profile of iDEL Therapeutics. iDEL Therapeutics is a startup founded in 2025, operating in Biotechnology and Pharmaceuticals. Developing a pipeline of cancer therapeutics delivered directly into the cytosol of tumor cells. Headquartered in Dortmund, Germany. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/idel-therapeutics/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "iDEL Therapeutics"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-05-15",
        "name": "iDEL Therapeutics - Profile Score 45/100",
        "reviewBody": "This is the official profile of iDEL Therapeutics. iDEL Therapeutics is a startup founded in 2025, operating in Biotechnology and Pharmaceuticals. Developing a pipeline of cancer therapeutics delivered directly into the cytosol of tumor cells. Headquartered in Dortmund, Germany. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/idel-therapeutics/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 45,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```